BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27121718)

  • 21. Clinical outcomes of stereotactic brain and/or body radiotherapy for patients with oligometastatic lesions.
    Inoue T; Katoh N; Aoyama H; Onimaru R; Taguchi H; Onodera S; Yamaguchi S; Shirato H
    Jpn J Clin Oncol; 2010 Aug; 40(8):788-94. PubMed ID: 20406944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereotactic body radiotherapy in the treatment of adrenal metastases.
    Ahmed KA; Barney BM; Macdonald OK; Miller RC; Garces YI; Laack NN; Haddock MG; Foote RL; Olivier KR
    Am J Clin Oncol; 2013 Oct; 36(5):509-13. PubMed ID: 22781389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes and toxicity for hypofractionated and single-fraction image-guided stereotactic radiosurgery for sarcomas metastasizing to the spine.
    Folkert MR; Bilsky MH; Tom AK; Oh JH; Alektiar KM; Laufer I; Tap WD; Yamada Y
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1085-91. PubMed ID: 24661662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy.
    Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Mantovani C; Fiandra C; Anglesio S; Ragona R
    Acta Oncol; 2009; 48(4):571-7. PubMed ID: 19031164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereotactic body radiation therapy for a new lung cancer arising after pneumonectomy: dosimetric evaluation and pulmonary toxicity.
    Testolin A; Favretto MS; Cora S; Cavedon C
    Br J Radiol; 2015; 88(1055):20150228. PubMed ID: 26290398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes for Spine Stereotactic Body Radiation Therapy and an Analysis of Predictors of Local Recurrence.
    Bishop AJ; Tao R; Rebueno NC; Christensen EN; Allen PK; Wang XA; Amini B; Tannir NM; Tatsui CE; Rhines LD; Li J; Chang EL; Brown PD; Ghia AJ
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1016-1026. PubMed ID: 26025777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc therapy and flattening filter free delivery: feasibility and early clinical results.
    Fiorentino A; Giaj-Levra N; Tebano U; Mazzola R; Ricchetti F; Fersino S; Di Paola G; Aiello D; Ruggieri R; Alongi F
    Radiol Med; 2017 Sep; 122(9):676-682. PubMed ID: 28447313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Five-Year Outcomes of High-Dose Single-Fraction Spinal Stereotactic Radiosurgery.
    Moussazadeh N; Lis E; Katsoulakis E; Kahn S; Svoboda M; DiStefano NM; McLaughlin L; Bilsky MH; Yamada Y; Laufer I
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):361-7. PubMed ID: 26232858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of stereotactic body radiation therapy in the management of adrenal metastases from non-small cell lung cancer.
    Gamsiz H; Beyzadeoglu M; Sager O; Demiral S; Dincoglan F; Uysal B; Onal E; Dirican B
    Tumori; 2015; 101(1):98-103. PubMed ID: 25702673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
    Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
    J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [An analysis of 20 consecutive patients treated with stereotactic body radiotherapy on Novalis Tx(®) for stage I non-small-cell lung cancer].
    Guillerme F; Clavier JB; Schumacher C; Falcoz PE; Bourrhala K; Santelmo N; Hassler S; Schott R; Quoix E; Massard G; Noël G
    Cancer Radiother; 2013; 17(4):272-81. PubMed ID: 23712043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung metastases treated with image-guided stereotactic body radiation therapy.
    Baschnagel AM; Mangona VS; Robertson JM; Welsh RJ; Kestin LL; Grills IS
    Clin Oncol (R Coll Radiol); 2013 Apr; 25(4):236-41. PubMed ID: 23352916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereotactic body radiation therapy for curative treatment of adrenal metastases.
    Rudra S; Malik R; Ranck MC; Farrey K; Golden DW; Hasselle MD; Weichselbaum RR; Salama JK
    Technol Cancer Res Treat; 2013 Jun; 12(3):217-24. PubMed ID: 23369155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I/II trials.
    Ghia AJ; Chang EL; Bishop AJ; Pan HY; Boehling NS; Amini B; Allen PK; Li J; Rhines LD; Tannir NM; Tatsui CE; Brown PD; Yang JN
    J Neurosurg Spine; 2016 May; 24(5):829-36. PubMed ID: 26799117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of Adrenal Metastases with Conventional or Hypofractionated Image-guided Radiation Therapy - Patterns and Outcomes.
    Buergy D; Rabe L; Siebenlist K; Stieler F; Fleckenstein J; Giordano FA; Wenz F; Boda-Heggemann J
    Anticancer Res; 2018 Aug; 38(8):4789-4796. PubMed ID: 30061250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 4π noncoplanar stereotactic body radiation therapy for head-and-neck cancer: potential to improve tumor control and late toxicity.
    Rwigema JC; Nguyen D; Heron DE; Chen AM; Lee P; Wang PC; Vargo JA; Low DA; Huq MS; Tenn S; Steinberg ML; Kupelian P; Sheng K
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):401-9. PubMed ID: 25482301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereotactic Body Radiation Therapy of Adrenal Metastases: A Pooled Meta-Analysis and Systematic Review of 39 Studies with 1006 Patients.
    Chen WC; Baal JD; Baal U; Pai J; Gottschalk A; Boreta L; Braunstein SE; Raleigh DR
    Int J Radiat Oncol Biol Phys; 2020 May; 107(1):48-61. PubMed ID: 32001383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypofractionated stereotactic body radiotherapy in spinal metastasis - with or without epidural extension.
    Anand AK; Venkadamanickam G; Punnakal AU; Walia BS; Kumar A; Bansal AK; Singh HM
    Clin Oncol (R Coll Radiol); 2015 Jun; 27(6):345-52. PubMed ID: 25726363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
    Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I dose escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma.
    Kim JW; Seong J; Lee IJ; Woo JY; Han KH
    Oncotarget; 2016 Jun; 7(26):40756-40766. PubMed ID: 27213593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.